Venture Map · Round
Accure Therapeutics — Series A · €7.6M
Announced 2020-05-26 · Barcelona · Biotech
Accure Therapeutics, formed by merging Iproteos and Bionure, launched with a €7.6M Series A led by Alta Life Sciences and backed by CDTI. It develops drugs for central nervous system diseases such as optic neuritis, multiple sclerosis, Parkinson's and epilepsy.
RoundSeries A
Amount€7.6M
LeadAlta Life Sciences
Date2020-05-26
CityBarcelona
SectorBiotech
